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Abstract
Purpose To report the use of real-time or quantitative
polymerase chain reaction (qPCR) in confirming the
diagnosis of tubercular uveitis.
Methods A qPCR assay using primers targeting the
MPB64 gene of Mycobacterium tuberculosis (MTB)
was developed. A standard curve for quantification of
mycobacterial load was generated. Vitreous fluid samples
from patients presumed to have tubercular uveitis were
a s s a y e dt oi d e n t i f ya n dq u a n t i fy the mycobacterial load.
The amount of the test sample product was interpolated
from the standard curve of cycle threshold values
generated from known starting copy number of standard
MTB DNA.
Results The copies of MTB genomes in the three test
samples studied were found to be 7.61×10
4, 4.53×10
4, and
1.43×10
5, respectively.
Conclusion qPCR detected and quantified MTB genome
from the vitreous fluid of eyes clinically suspected with
tubercular uveitis.
Keywords Quantitative polymerase chain reaction.
Tuberculosis.Tubercular uveitis
Polymerase chain reaction (PCR) is a molecular technique
for evaluation of very small amounts of DNA and RNA by
enzymatic amplification of nucleic acid sequences [1].
Several studies have linked specific pathogens to ocular
inflammatory syndromes using PCR [1]. It has had a major
impact on our ability to detect infectious agents causing
uveitis, including viral uveitis, mycobacterial intraocular
infections, infectious endophthalmitis, and protozoa eye
diseases [2]. The first use of PCR in detecting Mycobac-
terium tuberculosis (MTB) from the eye was reported from
aqueous samples of two patients with active retinal
vasculitis [3].
Quantitative (qPCR) or real-time PCR is a variant of
PCR using fluorescent probes [4] or SYBR Green dye [5]
which better allows the quantification of nucleic acid in the
sample. It facilitates the monitoring of the progress of a
PCR reaction in real time. One can start with minimal
amounts of nucleic acid and quantify the end product
accurately. There is no need for the post-PCR processing
which saves the resources and the time.
qPCR has been applied to infectious posterior uveitis
caused by viral infections and Toxoplasma gondii [6]. In a
clinicopathological study, it revealed the presence and
quantified the number of copies of MTB in the retinal
pigment epithelium (RPE) of an eye with granulomatous
panuveitis [5].
We report the use of qPCR in confirming tubercular
uveitis in three clinically suspected patients.
Methods
In a retrospective study, saved DNA from the vitreous
samples of three patients clinically suspected and found
positive for MTB by conventional PCR was used for qPCR
to confirm and quantitate the bacterial load. We used the
same set of primer pairs as used in the conventional PCR.
This allowed us to confirm our positive results through the
use of two PCR combinations.
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sample using DNeasy tissue kit (QIAGEN, Hilden,
Germany) according to the manufacturer’s instructions.
The extracted DNA specimens were stored at −20°C
until used. We used MPB64 gene primers for the
detection of MTB genome that was a part of previously
validated multiplex PCR assay for the diagnosis of
posterior uveitis [7].
The qPCR was performed using the forward primer
MPB1 (5′-TCC GCT GCC AGT CGT CTT CC-3′) and
reverse primer MPB2 (5′-GTC CTC GCG AGT CTA GGC
CA-3′), which amplified a 240-base-pair fragment of the
MPB64 single copy gene. The experiments were run in
triplicate with Light cycler 480 real-time PCR system
(Roche Applied sciences) and SYBR® Premix Ex Taq™
(Maxima TM SYBR Green qPCR Mastermix, Fermentas
Life Sciences) under reaction conditions which consisted of
a single step of 10-min incubation step at 95°C, followed
by four cycles of 95°C, 60°C, and 72°C for 30 s each, and
34 cycles consisting of 95°C, 56°C, and 72°C for 30 s each.
To confirm the specific target amplification, the real-time
amplification was followed by melting curve analysis from
65°C to 95°C. Non-template controls (NTC, consisting of
nuclease-free H2O) were used as negative controls for
amplification. The primer concentrations in the reaction
mixtures of 25 μl were 600 nM for each forward and
reverse primer. A total of 8 μl of DNA extracted from the
vitreous fluid sample was used as a PCR template. A total
of five standards prepared by cloning PCR amplified
product corresponding to MPB64 gene of MTB H37Rv
strain in pGEM-T easy vector. The plasmids DNA for the
copy number corresponding to a concentration from 10
3 to
10
7 copies of MTB bacterial genomes were used in the
present study.
Results
Amplification signals were observed for all the three test
samples studied (Fig. 1a, b). The melting curve analysis
indicated that the corresponding PCR products were
specific as a single peak was observed in both the MTB
standards and the test samples having a melting temperature
(Tm) of 88–90°C (Fig. 1c). The MTB standard DNA and
the three test samples were subjected to test in triplicates
and the mean value for copy numbers was calculated. The
standard curve was constructed based on crossing point
(Cp) values that demonstrated a significant linear relation-
ship (R
2=0.9959) between the Cp values and the log of the
starting copy numbers for each of the standard MTB DNA
(Fig. 2). The present study detected 7.61×10
4, 4.53×10
4,
and 1.43×10
5 copies of bacterial genome in the three test
samples, respectively.
Case examples
Case 1 A 25-year-old male presented with sudden
diminution of vision in the right eye since 4–5 months.
Fig. 1 a Amplification curve obtained from the analysis of Mycobac-
terium tuberculosis standard DNA run in triplicates ranging from 10
7 to
10
3 copies of bacterial genomes; b amplification curve obtained from the
analysis of three test samples in triplicates including one MTB standard
DNA as positive control; c melting curve analysis of the three test
samples including one MTB standard DNA as positive control indicating
the specificity of the reaction product. NTC non-template control
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motion in the right eye and 6/6 in the left eye. The
intraocular pressures were1 4a n d1 6m m H gi nt h er i g h t
and left eye, respectively. The left eye examination was
unremarkable. With a normal anterior segment, the right
eye revealed dense gray vitreous hemorrhage on poste-
rior segment examination and on B-scan ultrasound. The
tuberculin skin test (TST) sh o w e da ni n d u r a t i o no f1 9 ×
22 mm. He underwent pars plana vitrectomy (PPV) and
endolaser photocoagulation in the inferotemporal quad-
rant. Peroperatively, sheathing of inferotemporal vessels
with retinal vascularization was noted. The vitreous
fluid was sent for PCR analysis. He received oral
prednisolone (1 mg/kg daily) postoperatively. A MTB
load of 7.61×10
4 was detected by qPCR in the vitreous
sample. He was administered 4-drug antitubercular thera-
py. His BCVA is 6/6 in the right eye at 4 months follow-
up. The eye was quiescent and the fundus examination
showed clear media, sheathed vessels inferotemporally,
laser scars and regression of retinal neovascularization.
Case 2 A 35-year-old male with decreased vision in the
left eye since 9 months had BCVA of 6/9 in the right
eye and 6/60 in the left eye. The intraocular pressures
were 12 and 10 mmHg in the right and left eye, respectively.
He had posterior subcapsular cataract in both the eyes.
Posterior segment examination was unremarkable in the right
eye. Left eye had vitreous cells with snowballs. A subretinal
mass lesion was present in the upper temporal quadrant with
inferior peripheral exudative retinal detachment. (Figure 3a)
The TST showed an induration of 16×16 mm. Vitreous tap
of the left eye revealed a positive monoplex PCR, and
mycobacterial load of 4.53×10
4 by qPCR. The patient
received 4-drug antitubercular therapy and oral cortico-
steroids (1 mg/kg daily). At 6 months, his BCVA is 6/12 in
the left eye with posterior polar cataract and a scar at the site
of subretinal mass (Fig. 3b).
Case 3 A 40-year-old male with decreased vision in the
left eye since 3 months had BCVA of 6/6 in the right
Fig. 2 Mycobacterium tubercu-
losis DNA copies within the
test samples by interpolating in
the standard curve generated
by the analysis of standard MTB
DNA with known copy
number (10
3 to 10
7)
Fig. 3 Left eye fundus of case 2 showing subretinal mass in the upper
temporal quadrant with exudative retinal detachment (a) and best-
corrected visual acuity (BCVA) of 6/60. Six months after treatment
with antitubercular therapy and corticosteroids, the eye is quiescent
with BCVA of 6/12 and a large temporal scar at the site of subretinal
mass (b)
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pressures were 16 and 12 mmHg in the right and left
eye, respectively. There was a relative afferent pupillary
defect in the left eye. The right eye examination was
unremarkable. The left eye fundus examination revealed
extensive fibrovascular proliferation over the disc caus-
ing tractional retinal detachment. Retinal periphery
showed sheathed vessels with healed choroiditis scars.
The TST showed an induration of 40×45 mm. The
patient underwent PPV for dissection of the fibrovascu-
lar membranes with endolaser photocoagulation and
C3F8 tamponade. Monoplex PCR analysis of the
vitreous fluid demonstrated MTB, and qPCR detected
1.43×10
5 bacterial genomes. Along with oral predniso-
lone (1 mg/kg daily), four-drug antitubercular therapy was
added. At 4 months, the BCVA in the left eye was
counting fingers limited by a large macular scar.
Discussion
Besides early and fast diagnosis of MTB, the main
purpose of this study was to quantify the mycobacterial
load using qPCR amplification technique in these
patients. The results obtained by qPCR correlated with
clinical diagnosis of tubercular uveitis in our patients.
The finding of high mycobacterial loads in the ocular
fluids indicates that mycobacterial replication takes place
in the eye, suggesting a direct pathogenic role in
intraocular inflammation. Though the inflammation in
these eyes is clinically evident in retina and uvea, the
evidence of their isolation from the RPE suggests their
preferential localization in these cells [5]. Further, their
isolation directly from the RPE may yield a higher
b a c t e r i a ll o a da sc o m p a r e dt ow h e nt h e ya r ee x t r a c t e d
from the ocular fluids of eyes with posterior uveitis as
seen in our patients.
Tubercular uveitis poses a major diagnostic challenge in
endemic countries. In our experience, retinal vasculitis with
or without choroiditis in patients with latent/manifest
tuberculosis is a strong clinical predictor of tubercular
uveitis [8]. The clinical markers of tubercular uveitis are
considered in routine practice to initiate early eye-saving
treatment. Inflammation of retinal vessels is a known
association of systemic tuberculosis. The most common
etiologies of retinal vasculitis in our experience are
idiopathic and tuberculosis. We have previously described
the clinical presentation of PCR-positive tubercular retinal
vasculitis [9].
Specific diagnosis of the cause of infectious uveitis may
be difficult in part because of limited availability of
adequate ocular samples for diagnostic evaluation. Al-
though culture is regarded as the gold standard for the
diagnosis of tuberculosis [10], it is seldom available from
the ocular specimens. A very low sensitivity of acid-fast
bacilli smear and culture, particularly in ocular fluid
specimens and long time period (6–8 weeks) for this
bacteria to grow in culture are major limitations in
diagnosing ocular tuberculosis in routine clinical practice.
The PCR has emerged as a powerful tool for rapid
detection of the mycobacterial genome, with a high
specificity and a variable sensitivity [3, 9, 11–13].
Aqueous humor, vitreous, or subretinal fluid and even
tissue specimens have been used for PCR testing of MTB
DNA, with promising results [5, 12, 13]. In eyes where
the inflammation is predominantly confined to the
posterior segment, vitreous specimen may be obtained
for analysis by either straight needle vitreous aspiration
or ideally PPV. Vitreous aspiration is easier to perform
and can be done in an office setting, but carries an
increased risk of retinal traction and detachment. Since
most of the eyes with panuveitis or posterior uveitis
have sight-threatening disease, these eyes may in
addition benefit from PPV in terms of removal of the
whole vitreous body and a higher diagnostic yield of the
mycobacteria.
qPCR allows fast detection and quantification of
pathogen load in the tested specimen, with a minimized
risk of carryover and cross-contamination [14]. It may
be helpful in confirming the diagnosis of clinically
identified cases in laboratories having access to good
research facilities. The prognostic or diagnostic signifi-
cance of mycobacterial load in tubercular uveitis is as
yet not known. However it is well known that
tubercular uveitis may manifest clinically with variable
clinical manifestation that may include chronic anterior
uveitis, retinal vasculitis, and serpiginous-like choroiditis
or even subretinal mass due to choroidal granuloma [8].
Recently, Rao et al. found 1.7×10
6 copies of MTB
genome from the micro dissected RPE cells of paraffin
embedded sections of the globe from a patient with
panuveitis. The copy numbers 7.61×10
4 and 1.43×10
5 in
our patients 1 and 3, respectively, with the regressed
disease (retinal vasculitis) were comparable to case 2 with
active tubercular uveitis with subretinal mass lesion
(4.53×10
4). The relatively lower number of copies of
MTB in our cases compared to the previous report may be
attributed to different sites of sampling (Vitreous fluid vs.
RPE). Both these studies, however, justify a need to
correlate the DNA load with clinical presentation in terms
of morphology and severity of tubercular uveitis in a
larger set of patients.
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